Xpert® Tropical Fever Test on GeneXpert® Edge X System

Enrolling by invitation

Conditions studied: Malaria Fever, Zika, Dengue Fever, Leptospirosis, Chikungunya Virus Infection

In brief

This is a multi-site, observational, cross-sectional clinical study that includes geographically diverse sites within and outside the United States.

Key facts

Study ID

NCT07520279

Run by

Cepheid

People needed

2500

Starts

2025-08-18

Expected to finish

2027-02-28

Last updated by the study team

2026-04-09

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presents with AFI as defined for endemic populations or fever as defined in non-endemic populations or presents with fever as defined for nonendemic populations
• Clinical suspicion of disease caused by at least one of the following: Plasmodium spp, dengue virus, Zika virus, chikungunya virus, or Leptospira (endemic population)
• History of residence in or travel to an endemic geographic region within 3 months prior to specimen collection (endemic population)

You may not qualify if…

• Self-reported or known antibiotic or antimalarial use (oral or intravenous) within 3 days prior to enrollment (endemic and nonendemic population)
• History of residence in or trael to endemic geographic region as defined by protocol ≤ three months prior to specimen collection (nonendemic population)
• Clinical suspicion of infection caused by any of the following: Plasmodium spp., dengue virus, Zika virus, chikungunya virus, or Leptospira spp. (nonendemic population)

Where it is running

• Naval Health Research Center — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.